Cannabinoids are derived from the cannabis plant and are said to have anti-inflammatory properties when induced in animal cells. THC is an active ingredient of cannabinoids and it has the psychoactive side effects that cause dizziness among people who smoke cannabis.
Glaucoma is the leading cause of blindness and it is diagnosed in an eye exam when the blood supply in the eye is not enough which leads to damage to the optic nerve. Previous studies have stated that cannabinoid derivatives can reduce the blood pressure in the eye.
In california, it is now legal to research these cannabis derivatives so that they can hopefully be made into an effective drug to cure glaucoma. Especially now since cannabis is being legalized in some parts of America. This paper evaluates the results from this California research and investigates the potential therapeutic effects of cannabinoids against glaucoma.
Here is the full scientific article if you wish to download it.
In a survey of 9 glaucoma patients, medical marijuana was administered orally in THC capsules or by inhalation, in addition to their normal therapeutic regimen. The results demonstrated a reduction in intraocular pressure in all patients, and also the full therapeutic extent was reached with 4 patients. The decrease in intraocular was not sustained and all of the 9 patients decided to not continue with the THC treatment.
This study, however compelling, did not outline how cannabinoids can be effective in the treatment of glaucoma. The general feeling among the 9 patients was that the treatment was beneficial, however because of THC’s psychoactive effects, they decided they would not go further with it. THC was not sustainable because the body is able to build up a tolerance for it and it stops working.